Laevolac Arome Prune (Lactulose, Liquid)

Lactulose reaches the colon unchanged, where bacterial fermentation produces short‑chain acids that lower colonic pH. This acidic environment converts ammonia to ammonium, which is trapped and eliminated, while the increased osmotic pressure draws water into the bowel, softening stool and promoting evacuation.

The prescribed dose of lactulose is individualized by the treating clinician based on the patient’s condition, severity, and response. Dosage may be adjusted to achieve the desired clinical effect while minimizing adverse reactions.

Safety data for lactulose in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike stimulant laxatives that act on intestinal nerves, lactulose works osmotically and also lowers colonic ammonia, making it useful for both constipation and hepatic encephalopathy. It is generally gentler on the bowel but may cause more gas and bloating compared with bulk‑forming agents.

Store the liquid at ambient temperature, preferably below 25 °C, in its original container. Protect it from moisture, direct sunlight and extreme temperatures to maintain stability and potency.

The product is taken orally as a liquid. It can be measured with a calibrated dosing device and mixed with a small amount of water or juice if needed, following the prescribing clinician’s instructions.

Serious risks include severe electrolyte imbalance, dehydration, and rare allergic reactions. Patients with advanced liver disease should be monitored closely for signs of hepatic decompensation while on therapy.

Lactulose is contraindicated in patients with known hypersensitivity to lactulose or any component of the formulation, and it should be used with caution in individuals with severe renal impairment, intestinal obstruction, or active gastrointestinal bleeding.